In a significant step towards enhancing cardiac healthcare accessibility in India, Dehradun-based health-tech startup Sunfox Technologies has launched Spandan 4.0, a portable 12-lead ECG device that promises accurate and affordable heart monitoring outside traditional clinical settings.
Designed to be compact and lightweight, the Spandan 4.0 weighs just 12 grams and connects directly to Android smartphones via USB, eliminating the need for bulky equipment or batteries. The device boasts a trace accuracy of 99.7%, capable of detecting over 40 cardiac abnormalities such as arrhythmias, myocardial infarctions, and other heart dysfunctions, making it suitable for both personal and professional use.
The innovation targets underserved and rural areas where access to advanced cardiac diagnostics remains limited. Its portability and ease of use empower doctors, clinics, and even individuals to monitor heart health regularly, aiding early detection and timely intervention. The Spandan 4.0 generates instant ECG reports that can be saved, shared, or printed, facilitating seamless communication between patients and healthcare providers.
Healthcare professionals have welcomed the device for its precision and convenience. Dr. Apoorva from Kolkata uses Spandan 4.0 to track chronic cardiac patients, while practitioners like Mr. Ratnagiri in rural Andhra Pradesh leverage its portability to extend cardiac care to remote populations. In Punjab, preventive cardiology expert Mr. Gurvinder employs the device to identify early cardiac risks among high-risk patients. Telehealth providers such as Mr. Donald in Hyderabad also utilize Spandan 4.0 to enhance remote cardiac assessments during virtual consultations.
Sunfox Technologies aims to expand the device’s capabilities further by integrating artificial intelligence and electronic health record compatibility in future iterations. With its two-year warranty and no requirement for internet connectivity, the Spandan 4.0 stands out as an accessible and reliable tool that could transform cardiac healthcare monitoring across India.
The launch of Spandan 4.0 comes at a time when cardiovascular diseases continue to be a leading cause of mortality worldwide, underscoring the urgent need for accessible diagnostic tools. By democratizing ECG technology, Sunfox hopes to contribute significantly to early cardiac risk detection, reducing preventable deaths and improving patient outcomes.
